Year of creation: 2022
Status: SAS
Workforce: Not disclosed
% of the turnover dedicated to R&D: Not disclosed
Patents: Not disclosed
Accreditations: Not disclosed
MAILING ADDRESS
Biopôle Clermont-Limagne
2 rue Michel Renaud
63360 Saint-Beauzire
France
CONTACT
Simon Loiodice, CEO
Phone: Not disclosed
Email : Not disclosed
Website: https://karla-tx.com/
KARLA THERAPEUTICS
Immuno-based precision medicine for brain disorders.
Karla Therapeutics is a biopharmaceutical company developing immunotherapy for neuropsychiatric diseases. Our disruptive immuno-based precision medicine approach relies on proof-of-concept data and abundant literature pointing out the role of the immune system in various mental illnesses. We aim to pioneer immunopsychiatry to develop much better medicines to treat mental diseases.